Subcutaneous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Nursing Perspective

Autor: Elyse Murphy, Patty Riley, Mazen M Dimachkie, Jennifer M Watkins

Publikováno v: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 51(4)

Chronic inflammatory demyelinating polyneuropathy (CIDP), an immune-mediated peripheral neuropathy, is frequently treated with long-term maintenance intravenous immunoglobulin (IVIG). However, disadvantages of IVIG are the systemic adverse reactions,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c0b3d4dafe0efeb0b1ee5745c1c332
https://pubmed.ncbi.nlm.nih.gov/31107344

Variability in Intravenous Immunoglobulin G Regimens for Autoimmune Neuromuscular Disorders

Autor: Melvin Berger, Randy Broyles, Linda Rodden, Patty Riley

Publikováno v: Postgraduate Medicine. 125:65-72

We reviewed the intravenous immunoglobulin G (IVIG) dispensing records of a specialty pharmacy to characterize the IVIG treatment regimens used for chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) in community pract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea4c89a5dc3bc9292f7f48351a2bc0e
https://doi.org/10.3810/pgm.2013.03.2619

Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G

Autor: Melvin Berger, Elyse Murphy, Patty Riley, Garrett E. Bergman

Publikováno v: Southern medical journal. 103(9)

Primary immunodeficiency diseases (PIDDs) include a large class of genetically heterogeneous disorders which predispose patients to significant risk of serious and chronic/recurrent infections, as well as reduced quality of life (QoL). Intravenous im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d3d5c7398d864238c66ce089904a4b
https://pubmed.ncbi.nlm.nih.gov/20689488

Subcutaneous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Nursing Perspective.

Autor: Watkins JM; Questions or comments about this article may be directed to Jennifer M. Watkins, MSN APRN AGAC-NP, at watkins.jenni@gmail.com. She is a Nurse Practitioner, Neuromuscular Medicine, University of Kansas Medical Center, Kansas City, KS. Mazen M. Dimachkie, MD FAAN FANA, is Professor of Neurology and Director of the Neuromuscular Division, University of Kansas Medical Center, Kansas City, KS. Patty Riley, RN BAN CRNI, is Executive Medical Science Liaison, Immunoglobulins, Medical Affairs, CSL Behring, King of Prussia, PA. Elyse Murphy, BSN RN, is Associate Director, Medical Field Team, Immunoglobulins, Medical Affairs, CSL Behring, King of Prussia, PA., Dimachkie MM, Riley P, Murphy E

Publikováno v: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses [J Neurosci Nurs] 2019 Aug; Vol. 51 (4), pp. 198-203.

Importance of ancillary supplies for subcutaneous immunoglobulin infusion: management of the local infusion site.

Autor: Duff C; University of South Florida, Tampa, Florida (Ms Duff); Maxim Healthcare and Dallas Allergy and Immunology, both in Dallas, Texas (Ms Ochoa); and CSL Behring, LLC, King of Prussia, Pennsylvania (Mss Riley, Murphy, and Zampelli). Carla Duff, MSN, CPNP, CCRP, is a pediatric nurse practitioner in the Division of Pediatric Allergy and Immunology at the University of South Florida/All Children's Hospital in St Petersburg, Florida. She has many years of experience with clinical immunology and managing immunoglobulin replacement therapy for primary immunodeficient patients. Diana Ochoa, LVN, is a consultant for CSL Behring and was formerly a member of nurses advisory boards for Green Cross and Baxter. She has 17 years of experience with a large allergy and immunology practice in the Dallas area. Patty Riley, BAN, RN, CRNI®, is a medical science liaison in immunology for CSL Behring. She has 3 decades of clinical experience in adult critical care, neurology, and immunology. Elyse Murphy, BSN, RN, is a medical science liaison with CSL Behring with expertise in immunoglobulin therapies for more than 30 years in the disease state areas of immunology, hematology-oncology, neurology, and transplant. Annette Zampelli, MSN, CRNP, is a medical science liaison with CSL Behring with expertise in immunoglobulin therapies. She has worked for more than 20 years in the disease state areas of immunology, hematology-oncology, neurology, and transplant., Ochoa D, Riley P, Murphy E, Zampelli A

Publikováno v: Journal of infusion nursing : the official publication of the Infusion Nurses Society [J Infus Nurs] 2013 Nov-Dec; Vol. 36 (6), pp. 384-90.